CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Lupin Pharmaceuticals Inc. recalls Sertraline Hydrochloride Tablets USP

Read the official FDA notice

Published
17 Dec 2025
Units affected
52,128 bottles
Agency
FDA
Country
United States

The hazard

Defective container - seal not adhering to bottles

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Sertraline Hydrochloride Tablets USP, 100 mg, 90 Tablets bottles, Rx Only, Manufactured by: Lupin Pharmaceuticals, Inc., Naples, FL 34108, NDC 68180-353-09.

Brand / company
Lupin Pharmaceuticals Inc.
Codes / lots
Lot # QB00865, exp. date Feb 2028
Distribution
Nationwide.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 17 Dec 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.